On May 26, 2022, Jiang Wei, deputy director of Jiangsu Drug Administration, visited our company (Nanjing Kuancheng Technology Co., LTD.) to carry out special research on the review and approval of Class II medical devices, accompanied by Mr. Tang Guangjian, Chairman of the board, Ms. Tang Shiwen, and Ms. Shen Xiaoling, vice general manager.

　　The investigation team visited our company's science and technology exhibition hall, R&D and production workshop, office area, etc., got an in-depth understanding of our company's medical devices, regional layout, equipment and facilities, and carefully inquired about the 'urgent, difficult and anxious' problems encountered in the development of the enterprise, and had a discussion with the relevant person in charge to help the enterprise solve practical problems.

　　After listening to Kuancheng Technology medical device research, production, registration, the direction of follow-up work, as well as the problems that need to be solved by the enterprise, the investigation team responded one by one on the site.

　　At the forum, Deputy Director Jiang Wei and his delegation affirmed the development plan of our company as well as the R&D and investment of our products in the field of respiration and digestion. And said at the meeting, the provincial food and drug administration insists on people first, the concept of life is the highest, continuous attention to national policy, the experience of other province and think of thought, the anxious of nasty, enterprise solutions of difficult, to do a good job in service enterprises to explore the path of conducive to enterprise development and policy, actively do a good job to guide enterprise information reporting and site acceptance, Strengthen communication with enterprises to help enterprises develop.

　　At the same time, deputy director Jiang Wei pointed out that looking forward to Kuan-cheng technology in the field of respiration and digestion, to develop more, better, more urgently needed products, continue to play a good role in the prevention and treatment of respiratory diseases in the field of value, benefit patients.

　　Tang Guangjian, chairman of the board of Directors, expressed his gratitude to the provincial Drug Administration and Nanjing Branch at the meeting, and thanked the provincial Bureau and branch for their support and help in the development of Kuancheng technology. In the future, we will continue to deepen our efforts in the field of medical and health care, advance the medical market and household market together, integrate the product and service model, and build a domestic brand based on people's livelihood and health!